Insider Stock Trading History of Davis Thomas Andrew


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Davis Thomas Andrew since year 2005. The trader's CIK number is 1338185. At the time of this reporting, Davis Thomas Andrew is the Chief Medical Office of Avant Immunotherapeutics Inc . (stock ticker symbol AVAN). See this page for all insider trading activities at Avant Immunotherapeutics Inc .

Note that in the past Davis Thomas Andrew also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Davis Thomas Andrew since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2010-09-16 CLDX Avant Immunotherapeutics Inc Buy 2,500 3.78 9,437
2005-11-22 GNVC Genvec Inc Buy 5,000 1.82 9,100

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Davis Thomas Andrew (Chief Medical Office of Avant Immunotherapeutics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.